Cyclacel Pharmaceuticals Inc (CYCC) - Financial and Strategic SWOT Analysis Review

  • ID: 4284575
  • SWOT Analysis
  • 43 pages
  • GlobalData
  • Cyclacel Pharmaceuticals Inc
1 of 5

FEATURED COMPANIES

  • Abeona Therapeutics Inc
  • Celgene Corp
  • Deltagen Inc
  • Health Discovery Corp
  • HemaCare Corp
  • MORE
Cyclacel Pharmaceuticals Inc (CYCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cyclacel Pharmaceuticals Inc (Cyclacel) is a biopharmaceutical company that develops oral therapies. The company develops small molecule drugs that target various phases of cell cycle control for the treatment of cancer and other serious diseases. Its products include sapacitabine, seliciclib, CDK inhibitor and PLK inhibitor. Cyclacel’s sapacitabine is the drug candidate used to treat the patients with acute myeloid leukemia. The company’s seliciclib is an orally available, cyclin dependent kinase inhibitor. It offers products for the treatment of anti-infective, autoimmune, cardiovascular, ophthalmic and other non-oncology indications. The company operates in the US and the UK. Cyclacel is headquartered in Berkeley Heights, New Jersey, the US.

Cyclacel Pharmaceuticals Inc Key Recent Developments

Jan 09, 2018: Cyclacel Reviews 2017 Achievements and Announces Key Business Objectives for 2018
Nov 09, 2017: Cyclacel Pharmaceuticals Reports Third Quarter 2017 Financial Results
Aug 09, 2017: Cyclacel Pharmaceuticals Reports Second Quarter 2017 Financial Results
May 11, 2017: Cyclacel Pharmaceuticals Reports First Quarter 2017 Financial Results
Mar 28, 2017: Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abeona Therapeutics Inc
  • Celgene Corp
  • Deltagen Inc
  • Health Discovery Corp
  • HemaCare Corp
  • MORE
Section 1 - About the Company
  • Cyclacel Pharmaceuticals Inc - Key Facts
  • Cyclacel Pharmaceuticals Inc - Key Employees
  • Cyclacel Pharmaceuticals Inc - Key Employee Biographies
  • Cyclacel Pharmaceuticals Inc - Major Products and Services
  • Cyclacel Pharmaceuticals Inc - History
  • Cyclacel Pharmaceuticals Inc - Company Statement
  • Cyclacel Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Cyclacel Pharmaceuticals Inc - Business Description
  • R&D Overview
  • Cyclacel Pharmaceuticals Inc - Corporate Strategy
  • Cyclacel Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Cyclacel Pharmaceuticals Inc - Strengths
  • Cyclacel Pharmaceuticals Inc - Weaknesses
  • Cyclacel Pharmaceuticals Inc - Opportunities
  • Cyclacel Pharmaceuticals Inc - Threats
  • Cyclacel Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Cyclacel Pharmaceuticals Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jan 09, 2018: Cyclacel Reviews 2017 Achievements and Announces Key Business Objectives for 2018
  • Nov 09, 2017: Cyclacel Pharmaceuticals Reports Third Quarter 2017 Financial Results
  • Aug 09, 2017: Cyclacel Pharmaceuticals Reports Second Quarter 2017 Financial Results
  • May 11, 2017: Cyclacel Pharmaceuticals Reports First Quarter 2017 Financial Results
  • Mar 28, 2017: Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Cyclacel Pharmaceuticals Inc, Key Facts
  • Cyclacel Pharmaceuticals Inc, Key Employees
  • Cyclacel Pharmaceuticals Inc, Key Employee Biographies
  • Cyclacel Pharmaceuticals Inc, Major Products and Services
  • Cyclacel Pharmaceuticals Inc, History
  • Cyclacel Pharmaceuticals Inc, Other Locations
  • Cyclacel Pharmaceuticals Inc, Subsidiaries
  • Cyclacel Pharmaceuticals Inc, Key Competitors
  • Cyclacel Pharmaceuticals Inc, Ratios based on current share price
  • Cyclacel Pharmaceuticals Inc, Annual Ratios
  • Cyclacel Pharmaceuticals Inc, Annual Ratios (Cont...1)
  • Cyclacel Pharmaceuticals Inc, Interim Ratios
  • Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Cyclacel Pharmaceuticals Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Cyclacel Pharmaceuticals Inc, Performance Chart (2012 - 2016)
  • Cyclacel Pharmaceuticals Inc, Ratio Charts
  • Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Cyclacel Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • HemaCare Corp
  • Health Discovery Corp
  • GeneLink BioSciences, Inc.
  • Deltagen Inc
  • Celgene Corp
  • Abeona Therapeutics Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll